JKT · SAME.JK
PT Sarana Meditama Metropolitan Tbk
IDR 258+IDR 18 (+7.5%)
PT Sarana Meditama Metropolitan Tbk’s quoted price sits in the lower half of its reported 52-week range, 41.89% below the high.
Loading market information…
JKT · MTMH.JK · IDR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Murni Sadar Tbk’s quoted price sits in the lower half of its reported 52-week range, 40.49% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PT Murni Sadar Tbk’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PT Murni Sadar Tbk, together with its subsidiaries, provides health services and manages private hospitals in Indonesia. The company offers outpatient installation services, including specialist, family health, general, dental, tropical diseases, travel medicine, and pain clinics; laboratory services, such as clinical pathology, blood bank, biomolecular/PCR, microbiology, and anatomical pathology; radiotherapy, consists of LINAC, CT-simulator and immobilization, treatment planning system, and brachytherapy services. It also provides radiology services, including general X-Ray, ultrasonography (USG), mammography, 128 slice CT scan, 1.5 Tesla MRI, and interventional radiology; heart & vascular center, such as ECG, treadmill test, echocardiology, holter monitoring, and cardiac catheterization laboratory; endoscopy, contain esophagoscopy, gastroscopy, colonoscopy, bronchoscopy, and ERCP; medical rehabilitation, comprising physiotherapy, speech and occupation therapy, and orthotic prosthetic. In addition, the company offers general services, which includes emergency installation, and inpatient facility; intensive care; public facilities; operating theatres, ESWL, laporoscopic surgery, oncology, chemotherapy, pharmaceutical installations, medical checkup, lifestyle clinic, murni teguh IVF, home care, palliative care, EEG, EMG, and ambulance services; as well as operates IVF Centre. Further, it provides general facilities such as, auditorium, cafeteria, commercials area, fitness gym, and homestay. PT Murni Sadar Tbk was founded in 2010 and is based in Medan, Indonesia.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 258+IDR 18 (+7.5%)
PT Sarana Meditama Metropolitan Tbk’s quoted price sits in the lower half of its reported 52-week range, 41.89% below the high.
IDR 1,150+IDR 65 (+5.99%)
PT Mark Dynamics Indonesia Tbk’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
IDR 3,600-IDR 40 (-1.1%)
PT Prodia Widyahusada Tbk’s quoted price sits in the upper half of its reported 52-week range, 4.26% below the high.
IDR 191+IDR 1 (+0.53%)
Medela Potentia Tbk.’s quoted price sits in the lower half of its reported 52-week range, 36.33% below the high.
IDR 338-IDR 20 (-5.59%)
PT Kimia Farma (Persero) Tbk’s quoted price sits in the lower half of its reported 52-week range, 56.94% below the high.
IDR 1,570IDR 0 (0.0%)
PT Darya-Varia Laboratoria Tbk’s quoted price sits in the upper half of its reported 52-week range, 7.37% below the high.
IDR 195+IDR 2 (+1.04%)
PT Bundamedik Tbk’s quoted price sits in the lower half of its reported 52-week range, 20.73% below the high.
IDR 3,610IDR 0 (0.0%)
PT Merck Tbk’s quoted price sits in the lower half of its reported 52-week range, 19.78% below the high.
